Your shopping cart is currently empty

[DArg10, DAla20]TLQP-21, also known as a TLQP-21 analogue, functions as a C3aR agonist with an EC50 of 87 nM for β-arrestin recruitment. This compound induces calcium influx and can slightly enhance adrenaline-induced lipolysis, although not significantly. It is applicable for research on inflammatory diseases, metabolic disorders, and neurological disorders.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | [DArg10, DAla20]TLQP-21, also known as a TLQP-21 analogue, functions as a C3aR agonist with an EC50 of 87 nM for β-arrestin recruitment. This compound induces calcium influx and can slightly enhance adrenaline-induced lipolysis, although not significantly. It is applicable for research on inflammatory diseases, metabolic disorders, and neurological disorders. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.